|
|
|
|
|
|
Sponsored by: |
AstraZeneca |
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00646009 |
The purpose of this study is to compare the early onset of effect of Symbicort compared to Advair Diskus and Ventolin in adults with asthma
Condition | Intervention | Phase |
Asthma |
Drug: budesonide/formoterol Drug: fluticasone/salmeterol Drug: albuterol |
Phase III |
MedlinePlus related topics: | Asthma |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Crossover Assignment, Efficacy Study |
Official Title: | A Randomized, Multicenter, Placebo and Active-Controlled, Single-Dose, 4-Period, Crossover Study to Evaluate the Bronchodilating Effect of SYMBICORT pMDI Versus Advair Diskus and Ventolin HFA. |
Estimated Enrollment: | 48 |
Study Start Date: | March 2003 |
Study Completion Date: | October 2003 |
Primary Completion Date: | August 2003 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
1: Experimental
budesonide/formoterol
|
Drug: budesonide/formoterol |
2: Active Comparator
fluticasone/salmeterol
|
Drug: fluticasone/salmeterol |
3: Active Comparator
albuterol
|
Drug: albuterol |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | SD-039-0733, D5896C00733 |
First Received: | March 26, 2008 |
Last Updated: | March 26, 2008 |
ClinicalTrials.gov Identifier: | NCT00646009 |
Health Authority: | United States: Food and Drug Administration |
|
|
|
|
|
|